Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Endoron Medical Ltd. |
| Country | Israel |
| Start Date | Feb 01, 2023 |
| End Date | Jul 31, 2025 |
| Duration | 911 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190131747 |
Abdominal aortic aneurysm (AAA) is a focal enlargement of the abdominal aorta below the renal arteries and is found in up to 4 million patients globally each year.
If left untreated it can be fatal, so it is imperative to provide early, prophylactic treatment before a rupture occurs. The available treatment options are far from optimal: open surgery is a durable, life-long, but high-risk solution.
The alternative, EVAR, has lower immediate risks, but is a shorter-term solution and requires continual monitoring and secondary interventions.We have developed Aortoseal, a fixation and sealing implant for endovascular aneurysm repair that combines the best of both worlds: the stability of an open, sutured repair and the safety and low-risk delivery of EVAR.
Aortoseal will reduce the need for open surgery, the need for secondary procedures and time in the hospital, all leading to improved patient outcomes and projected healthcare savings over a 10-year period of ~9 bn across the EU.
Endoron Medical Ltd.
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant